FDA lowers age to 15 for OTC 'morning after' pill
This article was originally published in Scrip
Executive Summary
The US FDA on 30 April lowered the age for nonprescription access to Teva's emergency contraceptive pill Plan B One-Step (1.5 mg levonorgestrel tablet) to teenagers as young as 15 years - although that move does not comply with a 5 April order from a US district court judge that called for the agency to make levonorgestrel-based morning after pills available without a prescription and without point-of-sale or age restrictions within 30 days.